Company news

Renerve Limited news in 2026

Renerve Limited's news releases, calls and decks from 2026, newest first.

View company

Quarterly Investor Presentation

November 1, 2026

Becoming a substantial holder

October 28, 2026

Notification regarding unquoted securities - RNV

October 27, 2026

Quarterly Report Webinar

October 25, 2026

Q1 FY27 Activities Report and Appendix 4C

October 25, 2026

Positive 12-Month Data for NervAlign Nerve Guide Matrix

October 18, 2026

Positive 12-Month Data for NervAlign Nerve Guide Matrix

October 18, 2026

Positive FDA Feedback on NervAlign Nerve Guide Matrix

October 13, 2026

Change of Director's Interest Notice - P Savage

October 5, 2026

Change of Director's Interest Notice - M McGuire

October 5, 2026

Change of Director's Interest Notice - J Chick

October 5, 2026

Cleansing Notice

October 5, 2026

Application for quotation of securities - RNV

October 5, 2026

Proposed issue of securities - RNV

October 5, 2026

Notification regarding unquoted securities - RNV

October 5, 2026

Results of Meeting

October 5, 2026

ReNerve AGM Presentation

October 4, 2026

ReNerve completes first cases in Hong Kong and Malaysia

September 20, 2026

Change in substantial holding - J Chick

September 13, 2026

Change of Director's Interest Notice - J Chick

September 13, 2026

ReNerve and RMIT awarded $499k grant

September 6, 2026

Notice of Annual General Meeting/Proxy Form

September 2, 2026

ReNerve - Corporate Governance Statement

August 27, 2026

ReNerve - Appendix 4G

August 27, 2026

ReNerve - Full Year Results

August 27, 2026

ReNerve - 2026 Annual Report

August 27, 2026

ReNerve - Appendix 4E

August 27, 2026

Cleansing Notice

August 24, 2026

Application for quotation of securities - RNV

August 24, 2026

Proposed issue of securities - RNV

August 24, 2026

Quarterly Investor Presentation

August 18, 2026

Quarterly Investor Webinar

August 11, 2026

ReNerve Secures Marketing Approval in India

August 9, 2026

ReNerve Secures Marketing Approval in the Philippines

August 5, 2026

Change of Director's Interest Notice - J Chick

August 2, 2026

Q4 FY26 Activities Report and Appendix 4C

July 28, 2026

ReNerve Secures up to A$5 Million Funding Facility

July 8, 2026

ReNerve Secures Marketing Approval in Indonesia

July 5, 2026

ReNerve appoints J4 as second Empliq manufacturing partner

June 10, 2026

ReNerve appoints distribution partner for Malaysian Market

June 4, 2026

New distribution agreement for broader Hong Kong market

May 31, 2026

Quarterly Investor Presentation

May 8, 2026

Q3 FY26 Activities Report and Appendix 4C

April 30, 2026

Nerve Guide Matrix Enters Stage 3 of Commercial Development

April 15, 2026

1HFY26 Results Announcement

February 26, 2026

1HFY26 Appendix 4D and Half Year Report

February 26, 2026

Q2 FY26 Activities Report and Appendix 4C

January 29, 2026

ReNerve receives approval in Malaysia

January 14, 2026

Broader approval received in Hong Kong for Nerve Cuff

January 11, 2026

Decks in 2026